Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Growth Rate of the Immunohistochemistry (IHC) Market?
The size of the immunohistochemistry (IHC) market has witnessed substantial growth in the past few years. It’s projected to increase from $2.58 billion in 2024 to $2.78 billion in 2025, with a compound annual growth rate (CAGR) of 8.0%. The expansion in the historic period is as a result of acceptance in the clinic, industry standardization, development in cancer research, the implementation of automation in laboratories, and progress in clinical diagnostics.
What Growth Rate Is Forecasted for the Immunohistochemistry (IHC) Market by 2029?
In the coming years, the immunohistochemistry (IHC) market is predicted to undergo significant expansion. The market is projected to boost to $4.13 billion by 2029, growing at a compound annual growth rate (CAGR) of 10.4%. Factors driving this growth during the projected period includes the entrance of new market participants, increased demand in drug invention, inclusion of biomedical research, use in diagnosis, and the rise of automation and digitalization. Key trends during this anticipated period will involve multiplex IHC methods, digital pathology incorporation, improved antibody specificity, automation and compliance, and the application in biomarker discovery.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9267&type=smp
Which Key Companies Are Shaping the Future of the Immunohistochemistry (IHC) Market?
Major companies operating in the immunohistochemistry (IHC) market include Thermo Fisher Scientific Inc., F. Hoffmann-La Roche AG, The Merck Group, Danaher Corporation, PerkinElmer Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., Bio SB Inc., Agilent Technologies Inc., Abcam plc, Becton Dickinson and Company, Takara Bio Inc., Biocare Medical LLC, Bio-Genex Laboratories, Diagnostic BioSystems Inc., BioVision Inc., PHC Holdings Corporation, Abbott Laboratories, Leica Biosystems, Vector Laboratories, Indivumed GmbH, Qritive, Ionpath Inc., Reveal Biosciences, Akrivis Technologies Private Limited, LifeSpan BioSciences Inc., Enzo Life Sciences Inc., Epitomics Inc., GenScript Biotech, Histologix Ltd., NeoGenomics Laboratories Inc.
Which Factors Are Driving Demand in the Immunohistochemistry (IHC) Industry?
The rising incidence of chronic illnesses is predicted to stimulate the growth of the immunohistochemistry (IHC) market. Chronic diseases are long-term medical conditions that persist for at least three months and while they can be managed, they cannot be cured. The role of immunohistochemistry comes to the forefront in diagnosing such chronic diseases like cancer, cardiovascular diseases, and more owing to its unique benefits such as specificity, sensitivity (identifying specific antigens), swift results, among others. For example, data from the Centers for Disease Control and Prevention, a US-based national public health organization, in 2022 indicated that about 37.3 million individuals or 11.3% of the population in the United States are diabetic. Consequently, the escalating occurrence of chronic diseases is steering the expansion of the immunohistochemistry (IHC) market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=9267&type=smp
How Is the Immunohistochemistry (IHC) Market Segmented by Several Divisions?
The immunohistochemistry (IHC) market covered in this report is segmented –
1) By Product: Antibodies, Equipment, Reagents, Kits
2) By Applications: Diagnostics, Drug Testing, Other Applications
3) By End-Users: Hospitals And Diagnostic Laboratories, Research Institutes, Other End-Users
Subsegments:
1) By Antibodies: Primary Antibodies, Secondary Antibodies, Conjugated Antibodies
2) By Equipment: IHC Staining Systems, Tissue Processors, Slide Scanners, Microscopes
3) By Reagents: Detection Reagents, Blocking Reagents, Mounting Media
4) By Kits: Pre-prepared IHC Kits, Multiplex IHC Kits, Specialty Kits
What are the Emerging Market Trends Driving the Growth of the Immunohistochemistry (IHC) Industry?
Key players in the immunohistochemistry (IHC) market are prioritizing the enhancement of diagnostic precision through state-of-the-art technologies and superior quality reagents that augment the efficiency of tissue analysis in various scientific and clinical uses. The Neoflex multiomics mass spectrometry imaging (MSI) system represents an innovative imaging platform intended for meticulous tissue analysis, facilitating scientists to shift from discovery to clinical implementation via sophisticated mass spectrometry techniques, particularly for the spatial mapping of biomolecules within tissues. To illustrate, in June 2024, Bruker Corporation, a US organization that creates and produces analytical and diagnostic solutions as well as scientific apparatus, introduced their matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF/TOF) Neoflex Imaging Profiler for tissue imaging based on mass spectrometry. The Neoflex MSI system responds to the need for moving from discovery imaging towards clinical tissue research. It incorporates Bruker’s 10-kHz smartbeam 3D laser, upgraded imaging detectors, and is compatible with OME-TIFF file output using SCiLS Scope software.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/immunohistochemistry-ihc-global-market-report
Which Regions Are Driving Growth in the Immunohistochemistry (IHC) Market?
North America was the largest region in the immunohistochemistry (IHC) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the immunohistochemistry (IHC) market report during the forecast period. The regions covered in the immunohistochemistry (IHC) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9267
This Report Delivers Insight On:
1. How big is the immunohistochemistry (ihc) market, and how is it changing globally?
2. Who are the major companies in the immunohistochemistry (ihc) market, and how are they performing?
3. What are the key opportunities and risks in the immunohistochemistry (ihc) market right now?
4. Which products or customer segments are growing the most in the immunohistochemistry (ihc) market?
5. What factors are helping or slowing down the growth of the immunohistochemistry (ihc) market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
